Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (3): 191-192.
LI Hongmei1, SI Junling1, WANG Yanmin2,*
Received:2018-10-10
Revised:2020-06-28
Online:2019-03-20
Published:2019-04-17
CLC Number:
LI Hongmei, SI Junling, WANG Yanmin. One Case of Pulmonary Interstitial Edema and Edema of Lower Extremities Induced by Sucrose Iron Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 191-192.
| [1] 陈植. 不常见的药物性水肿[J].中级医刊,1990,(11):40-41. [2] 于步前,宋书凯.水肿机制与鉴别诊断[J].临床荟萃,1990,(7):305-306. [3] 吴小枫,林珍,史涛.蔗糖铁注射液致重症多形红斑型药疹1例[J].中国药物警戒,2017,14(7):443,445. [4] 王维忠. 102例药源性水肿文献分析[J]. 中国药业, 2004, 13(3):62-63. [5] 王少华. 肺水肿的X线表现[J]. 中国现代药物应用, 2009, 3(23):53-54. [6] Shiotani S, Kobayashi T, Hayakawa H, et al.Postmortem pulmonary edema: A comparison between immediate and delayed postmortem computed tomography[J]. Legal Medicine, 2011, 13(3):151-155. [7] Shin N Y, Hong Y J, Kim A H, et al.Diffuse Interstitial Infiltrative Lung Metastasis of Malignant Melanoma: a Case Report[J]. Korean Journal of Radiology Official Journal of the Korean Radiological Society, 2011, 12(2):252-255. [8] 向兴利, 杜智敏, 马志习, 等. 高原肺水肿的CT诊断[J]. 中华放射学杂志, 2002, 36(2):137-138. [9] 黄依莲. 肺水肿的影像学鉴别诊断[J]. 亚太传统医药, 2010, 6(6):117-119. [10] Hsu K F, Ou K W, Lee S C, et al.Re-expansion Pulmonary Edema After Insertion of Chest Tube for Pneumothorax[J]. The Journal of Trauma: Injury, Infection, and Critical Care, 2011, 70(3):761. [11] 苏宪英,石光,张欣,等.引起药物性水肿的常见药物及发生机制[J].中国民族民间医药,2016,25(6):163,165. [12] 郝爱华,曾庆娟,江洁.心源性肺水肿的影像学表现及其鉴别诊断[J].中国中西医结合影像学杂志,2014,12(5):518-520. [13] 杨作成. 小儿心源性肺水肿[J].实用儿科临床杂志,2011,26(22):1693-1695. [14] 凌文哲,金学荣,张海宇.药物过敏所致急性肺水肿的影像学特点分析[J].山东医药,2012,52(23):67-68. [15] 吴颖其, 姜玲, 张圣雨, 等.我院蔗糖铁注射液药物利用评价标准的建立及应用[J].中国药房, 2017, 28(2) :270-273. [16] 倪寂,冯伟民,范赟婷.2016年某院蔗糖铁注射液临床使用评价及分析[J].中国药业,2017,26(22):89-92. [17] 李春霞. 不同补铁途径治疗缺铁性贫血的临床研究[J].中国实用医药,2013,8(36):117-118. [18] Derman R, Roman E, Modiano M R, et al.A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia[J]. American Journal of Hematology, 2017, 92(3):286-291. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
